(Q44060081)

29 November 2017

Association between high-density lipoprotein and cognitive impairment in the oldest old. (English)

1 reference

29 November 2017

1 reference

cognitive dysfunction

1 reference

8

Rudi G J Westendorp

1 reference

29 November 2017

3

Jacobijn Gussekloo

1 reference

29 November 2017

Eric van Exel

1

1 reference

29 November 2017

Anton J M de Craen

2

1 reference

29 November 2017

Peter Houx

4

1 reference

29 November 2017

Annetje Bootsma-van der Wiel

5

1 reference

29 November 2017

Peter W Macfarlane

6

1 reference

29 November 2017

Gerard J Blauw

7

1 reference

29 November 2017

1 June 2002

1 reference

29 November 2017

1 reference

29 November 2017

51

1 reference

29 November 2017

716-721

1 reference

29 November 2017

6

1 reference

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

29 November 2017

1 reference

Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

Plasma lipids and geriatric assessment in a very aged population of south Italy.

21 January 2018

1 reference

High-density lipoprotein cholesterol in differential diagnosis of senile dementia.

21 January 2018

1 reference

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

21 January 2018

1 reference

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

The role of cerebral ischemia in Alzheimer's disease

21 January 2018

1 reference

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study

21 January 2018

1 reference

High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study.

21 January 2018

1 reference

Frequency and clinical determinants of dementia after ischemic stroke

21 January 2018

1 reference

The Mini-Mental State Examination: A Comprehensive Review

21 January 2018

1 reference

Do general practitioners miss dementia in elderly patients?

21 January 2018

1 reference

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

21 January 2018

1 reference

The importance of inflammatory mechanisms in Alzheimer disease.

21 January 2018

1 reference

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

Statins and the risk of dementia

21 January 2018

1 reference

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10220

1 reference

29 November 2017

1 reference